INTRODUCTION
Lymphatic system is an important part of our immune system. Lymphadenopathy may be a presenting sign and symptom of patient's illness or may be an incidental finding in patients being examined for various reasons. It is the readiness with which particulate matter can enter the lymphatics, which gives these vessels and nodes their great importance as a pathway for spread of infection and cancer. The body has approximately 600 lymph nodes, but only those in the submandibular, axillary or inguinal regions may normally be palpable in healthy people. Lymphadenopathy is an abnormal increase in size and or altered consistency of lymph nodes. It is a clinical manifestation of regional or systemic disease and serves as an excellent clue to the underlying disease. There are various classifications of lymphadenopathy, but a simple and clinically useful system is to classify lymphadenopathy as "generalized" if lymph nodes are enlarged in two or more noncontiguous areas or "localized" if only one area is involved. [1] [2] [3] Distinguishing between localized and generalized lymphadenopathy is important in formulating a differential diagnosis. In primary care patients with unexplained lymphadenopathy, approximately three fourths of patients will present with localized lymphadenopathy and one fourth with generalized lymphadenopathy. 2, 3 Generalized lymphadenopathy is frequently associated with nonmalignant disorders such as tuberculosis, infectious mononucleosis (Epstein-Barr virus (EBV) or cytomegalovirus (CMV)], toxoplasmosis, AIDS, other viral infections, systemic lupus erythematosus (SLE), and mixed connective tissue disease and malignant disorders like lymphoma and leukemia. The size and texture of the lymph node(s) and the presence of pain are useful parameters in evaluating a patient with lymphadenopathy. Nodes <1.0 cm 2 in area (1.0 cm x 1.0 cm or less) are almost always secondary to benign, nonspecific reactive causes. In one retrospective analysis of younger patients (9-25 years) who had a lymph node biopsy, a maximum diameter of >2 cm served as one discriminant for predicting that the biopsy would reveal malignant or granulomatous disease. Another study showed that a lymph node size of 2.25 cm 2 (1.5 cm x 1.5 cm) was the best size limit for distinguishing malignant or granulomatous lymphadenopathy from other causes of lymphadenopathy. Patients with node(s) <1.0 cm 2 should be observed after excluding infectious mononucleosis and/or toxoplasmosis unless there are symptoms and signs of an underlying systemic illness. 4 Our understanding of the epidemiology of lymphadenopathy in family practice is limited by the scarcity of relevant literature. Only one study provides reliable population-based estimates. Findings from this Dutch study revealed a 0.6 percent annual incidence of unexplained lymphadenopathy in the general population.
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METHODS
All patients of generalized lymphadenopathy admitted the medical wards who fulfilling inclusion and exclusion criteria are included to my study. This study was undertaken over a period of one year. Valid consent was taken from all the patients who were included this study. Proper history from all patients were taken and relevant examination of all systems specially lymphreticular system were done. Among all patients lymph nodes size <1.5 cm mostly were due to reactive lymphadenopathy, lymph nodes size 1.5 -3 cm were mainly due to malignant diseases (52.1%) and non-malignant granulomatous cases (43.7%) and lymph nodes size >3cm were due to mainly nonmalignant granulomatous cases (64.1%) and malignant cases (35.9%). Lymph nodes size in different regions was statistically significant for diagnosis of different cases of generalized lymphadenopathy (p<0.0001) except in popliteal region (p=0.4582).
Matted lymph nodes were mainly seen in cervical followed by inguinal regions. Matted lymph nodes in non-malignant granulomatous and malignant cases were 75.4% and 24.6% respectively. These matted lymph nodes were statistically significant in cervical region (p<0.0001) and inguinal region (p=0.0321).
Among 116 patients soft lymph nodes were mostly due to reactive lymphadenitis and firm lymph nodes were due to malignant and non-malignant granulomatous disease and hard lymph nodes were due to malignant diseases. Lymph nodes consistency in different regions was statistically significant for diagnosis of different cases of generalized lymphadenopathy (p<0.0001) except in popliteal region (p=0.1249).
Among the patients lymph nodes with sinus were seen commonly in cervical followed by inguinal region and axillary region. These lymph nodes with sinus were seen mainly non-malignant granulomatous cases (87% Out of 69 non-malignant cases FNAC showed proper diagnosis in 84.6% TB cases, 76% reactive lymphadenopathy, 20% other granulomatous diseases and HPE give 100% definite diagnosis in all non-malignant cases. Accuracy of FNAC in diagnosis of malignant diseases was 80.8% where in non-malignant diseases it was 76.8% and overall 78.4%. Figure 1 ).
Figure 1: Diagnosis of generalized lymphadenopathy of the cases.
So diagnosis of generalized lymphadenopathy following decreasing order-TB lymphadenopathy (33.6%), lymphoma (22.4%), reactive lymphadenitis (21.6%), acute leukemia (8.5%), CLL (6.9%), Kikuchi's disease (3.4%), metastatic cases (1.8%), Castleman's disease (0.9%), sarcoidosis (0.9%).
DISCUSSION
We are seeing so many cases of generalized lymphadenopathy referring from different primary healthcares to our apex institute and we study those patients admitted to our medical wards.
Most common presenting features of our patients were fever (67.2%) followed by weight loss (61.2%) and other features in decreasing order were-fatigability, swelling of lymph nodes, dyspnea, night sweat, skin rash and prominent bleeding manifestation and only 17% patients presented with B symptoms.
Taghipour ZS et al study revealed that cough, fever, night sweat, weight loss were statistically significant in relation to diagnosis of different cases which partially support our study. 6 In our study among the 116 patients of generalized lymphadenopathy most common involved lymph node area was cervical groups in 86 (74.1%) patients, followed by axillary groups in 73 (62.9%) patients, inguinal groups in 68 (58.6%) patients, epitrochlear lymph node in 23 (19.8%) patients and popliteal group in 10 (8.6%) patients.
Different studies throughout the world also revealed that cervical groups of lymph nodes were most commonly involved which was similar to present study.
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Most of patients (86.9%) patients of epitrochlear lymphadenopathy were due to malignant causes in our study.
Selby CD et al study of the enlarged epitrochlear lymph nodes: an old physical sign revisited showed that enlargement of these nodes was common in most of the lymphoproliferative disorders except Hodgkin's disease.
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Among the patients of generalized lymphadenopathy in our study lymph nodes size <1.5cm were mainly due to reactive causes where size >1.5cm were due to malignant and non-malignant granulomatous cases.
Bedi RS et al. finding in the clinico-pathological study of superficial lymphadenopathy in Northern India supported this finding. 12 Another study from Switzerland published in 2010 also supported this finding. 13 Pangalis conducted a study in which he analyzed lymph nodes of 220 patients of which biopsies produced no malignancies in lymph nodes smaller than 1 cm 2 , 8% of the lymph nodes sized between 1-2.25 cm 2 were malignant, and 38% of patients whose lymph nodes were larger than 2.25 cm 2 were found to have a malignant disease. 14 Another publication from Turkey published in 2011revealed that in patients aged 9-25, lymph nodes larger than 2 cm were predictive of granulomatous diseases or cancer. 15 Matted lymph nodes in cervical, axillary and inguinal regions were mainly due to non-malignant granulomatous diseases (75.4%). In cases of TBLN matted lymph nodes were 69%.
In Dandapat et al study of peripheral lymph node tuberculosis revealed that matted lymph nodes seen in 55% of TBLN cases where Subrahmanyam et al study it was seen in 68% patients. 16, 17 These lymph nodes with sinus were seen mainly non-malignant granulomatous cases (87%). Lymph nodes with sinus in different regions were statistically not significant (p>0.05) except in cervical region (p=0.0445).
In Dandapat et al study it was seen that lymph nodes with sinuses in TBLN cases was 13% where Subrahmanyam et al study it was 10.5% cases. 16, 17 USG examination of 116 cases showed that most common abnormality was retroperitoneal lymphadenopathy (42.2%) followed by hepatomegaly (31%) and splenomegaly (25.9%). In CXR of 116 patients mediastinal widening (39.7%) was the most common finding followed by pleural effusion (20.7%).
Dursun Tatar et al study among TBLN patients showed that mediastinal lymph node involvement was found to be the commonest pulmonary manifestation of TBLN cases (141). Comparison of RPLN and MW was statistically significant (p<0.0001) but comparison between RPLN and MW in relation to different diseases was not statistically significant (p=0.0609).
In present study LDH was done all the patients and it was seen that LDH was increased in 25 (53.2%) malignant cases and 21(30.4%) non-malignant cases. In malignant cases LDH was increased 71.4% in ALL, 61.1% in NHL, 50% in HD, 37.5% in CLL and 33.3% in AML. In nonmalignant cases it was increased mainly TBLN cases.
Kornberg et al showed that LDH was increased in 79% of ALL cases whereas in lymphoma cases it was increased in only 16% cases (18).
Bierman et al study shown that LDH increased in ALL and lymphoma were 87% and 86% respectively (19).
Berthier S et al study showed that LDH level elevations were seen in 60% of benign cases, 36% in malignant cases and undetermined in 4% (20) .
In our study out of 116 cases FNAC give definite diagnosis 80.8% malignant cases where 76.8% in nonmalignant cases. HPE shown definite diagnosis in 100% cases both malignant and non-malignant diseases. Among 47 malignant cases FNAC gave proper diagnosis 100% in acute leukemia, 80.8% in lymphoma, 62.5% in CLL, 100% in metastatic carcinoma and HPE give 100% definite diagnosis in all malignant cases. Out of 69 nonmalignant cases FNAC gave proper diagnosis in 84.6% TB cases, 76% reactive lymphadenopathy, 20% other granulomatous diseases and HPE give 100% definite diagnosis in all non-malignant cases. Accuracy of FNAC in diagnosis of malignant diseases was 80.8% where in non-malignant diseases it was 76.8% and overall it was78.4%.
Comparison of HPE and FNAC in diagnosis of diseases were statistically significant (p<0.0001).
Thomas JO et al study of FNAC in management of peripheral lymphadenopathy showed that the overall accuracy rate of lymph node aspiration was 89.5%. 21 Steel BL et al study of FNAC in diagnosis of lymphadenopathy showed that the most challenging lesions to assess using FNAC were lymphomas, accounting for 15 of the 23 false negatives. FNAC of nodes provides a high level of diagnostic accuracy, as shown by the 3.4% false-negative and 0.9% false-positive rates. Studies of the developing countries revealed that tuberculosis was the most common cause that was similar with present study. 9, 10 Lymphoma was the 2 nd most common cause in Ochicha O, Edino ST et al study of pathology of peripheral lymph node biopsies in Kano, Northern Nigeria that was similar to our study. 10 Overall malignancy (40.5%) was a major cause of generalized lymphadenopathy in our study which contradicts several studies. 7, 9 Several studies also showed that malignancy was a major cause of lymphadenopathy that was similar to our study. 10, 23 Among malignant cases lymphoma was a major cause in our study that finding was also supported by different studies.
9,10,23 NHL was higher than HD in our study which also supported different studies. 24, 25 Reactive lymphadenitis was the 3 rd most common cause in our study which contradicts several studies. 7, 9 Several studies throughout the world showed that reactive lymphadenitis was the most common cause followed by TB lymphadenopathy which contradicts our study. 6, 8 
CONCLUSION
Males predominate in generalized lymphadenopathy cohorts across all age groups. Tuberculous infection is the commonest cause of generalized lymphadenopathy in India. Non malignant etiologies predominate as causes of generalized lymphadenopathy in our setting. TB lymphadenopathy is the most common cause of generalized lymphadenopathy followed by lymphoma and reactive lymphadenitis.
Cervical nodes are most commonly enlarged, irrespective of the etiology of lymphadenopathy. Lymph nodes size <1.5 cm in are predominantly benign reactive, while a size >1.5 cm are associated with benign granulomatous and malignant diseases. Epitrochlear lymphadenopathy has the strongest association with malignant causes. Sinus tracts are most common with cervical nodes and tuberculous etiology. Mediastinal widening and retroperitoneal lymphadenopathies are the commonest imaging associations. Elevation of LDH is associated with hematological malignancies and tuberculosis. Less than 20% patients with TBLN had co-existing pulmonary tuberculosis. FNAC is a safe and cost effective diagnostic tool with good sensitivity for all causes of lymphadenopathy.
